HEPARIN LOCK FLUSH Drug Patent Profile
✉ Email this page to a colleague
When do Heparin Lock Flush patents expire, and when can generic versions of Heparin Lock Flush launch?
Heparin Lock Flush is a drug marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, and Solopak. and is included in seventeen NDAs.
The generic ingredient in HEPARIN LOCK FLUSH is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Heparin Lock Flush
A generic version of HEPARIN LOCK FLUSH was approved as heparin sodium by HOSPIRA on April 28th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HEPARIN LOCK FLUSH?
- What are the global sales for HEPARIN LOCK FLUSH?
- What is Average Wholesale Price for HEPARIN LOCK FLUSH?
Summary for HEPARIN LOCK FLUSH
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 17 |
Clinical Trials: | 1,008 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HEPARIN LOCK FLUSH at DailyMed |
![HEPARIN LOCK FLUSH drug patent expirations Drug patent expirations by year for HEPARIN LOCK FLUSH](/p/graph/s/t/HEPARIN_LOCK_FLUSH-patent-expirations.png)
Recent Clinical Trials for HEPARIN LOCK FLUSH
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Wonju Severance Christian Hospital | N/A |
Amphia Hospital | Phase 2 |
Haaglanden Medical Centre | Phase 2 |
US Patents and Regulatory Information for HEPARIN LOCK FLUSH
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | HEPARIN LOCK FLUSH | heparin sodium | INJECTABLE;INJECTION | 005264-010 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Solopak | HEPARIN LOCK FLUSH | heparin sodium | INJECTABLE;INJECTION | 088459-001 | Jul 26, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Smith And Nephew | HEPARIN LOCK FLUSH | heparin sodium | INJECTABLE;INJECTION | 087904-001 | Apr 20, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Luitpold | HEPARIN LOCK FLUSH | heparin sodium | INJECTABLE;INJECTION | 089063-001 | Oct 9, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Smith And Nephew | HEPARIN LOCK FLUSH | heparin sodium | INJECTABLE;INJECTION | 087959-001 | Apr 20, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Smith And Nephew | HEPARIN LOCK FLUSH | heparin sodium | INJECTABLE;INJECTION | 087958-001 | Apr 20, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Solopak | HEPARIN LOCK FLUSH | heparin sodium | INJECTABLE;INJECTION | 088457-001 | Oct 25, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |